Heroin addiction and pregnancy

Area of Science:

• Obstetrics and Gynecology
• Neonatal Medicine
• Addiction Psychiatry

Background:

• Heroin addiction in pregnant individuals is associated with distinct demographic profiles, including younger age and minority ethnic group representation.
• Pregnancy complicated by heroin use presents significant maternal and fetal health risks, impacting both mother and neonate.

Purpose of the Study:

• To outline the demographic characteristics of pregnant heroin addicts.
• To detail the medical and obstetrical complications associated with heroin addiction during pregnancy.
• To review the potential effects of maternal heroin addiction and methadone treatment on neonates.

Main Methods:

• Review of existing literature on heroin addiction in pregnancy.
• Analysis of maternal and neonatal complications.
• Examination of studies on methadone treatment in pregnant addicts and animal offspring.

Main Results:

• Pregnant heroin addicts are often younger, unmarried, and from minority groups.
• Common maternal complications include malnutrition, infections, preeclampsia, and bleeding.
• Fetal/neonatal issues encompass fetal death, growth retardation, prematurity, and withdrawal symptoms.

Conclusions:

• Heroin addiction during pregnancy leads to severe maternal and neonatal complications.
• Animal studies suggest potential long-term developmental issues in offspring exposed to heroin or methadone in utero.
• The use of methadone for pregnant addicts requires careful consideration due to potential adverse effects on offspring development.